Evidence map›Paper›PMID 32802453›Full record

ReviewJournal of thoracic disease2020

Gender differences in aortic valve replacement: is surgical aortic valve replacement riskier and transcatheter aortic valve replacement safer in women than in men?

Maria Giulia Caponcello, Lucia M Banderas, Carmen Ferrero, Carsten Bramlage, Martin Thoenes, Peter Bramlage

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Maria Giulia CaponcelloDepartamento Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, Sevilla, Spain.
Lucia M BanderasDepartamento Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, Sevilla, Spain.
Carmen FerreroDepartamento Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, Sevilla, Spain.
Carsten BramlageInstitute for Pharmacology and Preventive Medicine, Cloppenburg, Germany.
Martin ThoenesDepartamento Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, Sevilla, Spain.
Peter BramlageDepartamento Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, Sevilla, Spain.
Universidad de Sevilla · ESIPPMed (Germany) · DELeman University · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aortic stenosis (AS) is a progressive and degenerative disease that necessitates valve replacement through either surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). Various studies have shown that, unlike for TAVR, SAVR is associated with an elevated risk for women as compared to men. The aim of this review is to better understand the risks and their possible causes, associated with the use of both TAVR and SAVR in female patients. Our systematic review included studies published between 2012 and 2020, identified through specific searches of PubMed. Compatibility of publications, determined by the use of pre-defined inclusion/exclusion criteria, resulted in 15 articles being used in our review. Overall, more men than women undergo SAVR, but our findings confirmed that SAVR is associated with worse outcomes in women in the short-term. Reasons for a higher 30-day mortality post-SAVR in women include an increased age, higher in-hospital mortality and, possibly baseline comorbidities and anatomical differences. There was no difference observed in 30-day mortality between men and women undergoing TAVR. Female patients appear to have a better longer-term survival post-TAVR than their male counterparts. Understanding the reasons why women have worse outcomes post-SAVR is essential for ensuring appropriate treatment selection for patients with AS, as well as for achieving the best possible long-term and safety outcomes for these patients.

Indexed as

gender disparitiessurgical aortic valve replacement (SAVR)Transcatheter aortic valve replacement (TAVR)women

Identifiers

PMID32802453
PMCPMC7399394
OpenAlexW3041216408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.